sion profi les were compared with that of medium-treated control cells incubated for the same time. Cells from four individual mice of each genotype were used, and each mouse served as its own medium-treated control. In the time-course experiment, cells from two mice were treated with 10 ng/ml LPS or live E. coli (one bacterium per macrophage) for increasing times, and their gene expression profi les were compared with that of the preceding time point in a loop design. Total RNA for microarray analysis was isolated with TRIzol reagent (Invitrogen) and RNeasy columns (Qiagen). RNA integrity was assessed using the 2100 Bioanalyzer (Agilent Technologies). The Operon Mus musculus ver. 1.1 probe set (Qiagen) consisting of >13,000 oligonucleotide probes (70mers) was printed in the Massachusetts General Hospital (Cambridge, MA) microarray core facility using an Omnigrid 100 (GeneMachines) on CodeLink-activated slides (Amersham). RNA was reverse transcribed and differentially labeled with Cy3 and Cy5 dyes (Amersham) using the Atlas PowerScript fl uorescent labeling kit (BD Biosciences). Labeled samples were hybridized overnight using an automated hybridization station (Genomic Solutions). Fluorescent images from the arrays were acquired using a GenePix 4000B microarray scanner and its accompanying software (Axon Instruments). Data were normalized using the Bio-Array Software Environment (http://base.thep.lu.se/). Higher-level data and statistical analysis was performed using the GeneSpring (Silicon Genetics) software. A detailed analysis of the entire microarray data set has been published elsewhere ( 18 ) .
Quantitative real-time PCR
Bone marrow-derived macrophages were treated with PBS (vehicle) or 10 ng/ml LPS for 2 h. Total RNA was isolated using Trizol reagent (Invitrogen) and the E.Z.N.A. Total RNA kit (Omega Bio-Tek). RNA integrity and purity were analyzed with an Experion automated electrophoresis system (Bio-Rad) and a ND-1000 spectrophotometer (NanoDrop Technologies). Purifi ed total RNA was reverse transcribed with MMLV reverse transcriptase (Invitrogen), and quantitative real-time PCR was performed using SYBR Green PCR Master Mix and a 7900HT Fast real-time PCR system (Applied Biosystems). Relative mRNA expression was calculated from standard curves, constructed by serial dilution of gel-purifi ed PCR products, and normalized to 18S rRNA expression. Primer pairs used were as follows: cholesterol 25-hydroxylase ( Ch25h ) forward primer 5 ′ -TGCTACA ACGGTTCGGAGC-3 ′ and reverse primer 5 ′ -AGAAG CCC ACGTAAGTGATGAT-3 ′ , Cyp27a1 forward primer 5 ′ -CCAGGCACAGGAGAGTACG-3 ′ and reverse primer 5 ′ -GGGCAAGTGCAGCACATAG-3 ′ , and Cyp7b1 forward primer 5 ′ -AGCTGCTTACTGATGACGACC-3 ′ and reverse primer 5 ′ -AG T-GAGCCACAGAATGCAAAT-3 ′ .
Oxysterol measurements
Bone marrow-derived macrophages were treated with PBS (vehicle) or 10 ng/ml LPS for 6 or 24 h. Supernatant was collected, and dead cells and cell debris were removed by centrifugation. Adherent macrophages were washed twice with PBS before harvesting by scraping in 200 µl PBS. Supernatants and scraped cells were stored at Ϫ 80°C until analyzed. Total protein concentration was measured with the BCA protein assay kit (Pierce). For 25hydroxycholesterol measurements, cells or cell culture medium were extracted according to Folch, Lees, and Sloane Stanley ( 19 ) and subsequently analyzed by isotope dilution GC-MS using deuterium-labeled internal standard as described earlier ( 7 ) . ELISA RAW264.7 cells were treated with either increasing concentrations of 25-hydroxycholesterol or fi xed concentrations of 25 or liver X receptor ␣ (LXR ␣ ) ( 12, 13 ) , involved in the regulation of lipid metabolism. It has been questioned whether oxysterols are natural ligands for LXR ( 14 ) , but some support for their role as ligands has been obtained from experiments in triple knockout mice defi cient in the biosynthetic enzymes for 24-, 25-, and 27-hydroxycholesterol. While cholesterol feeding induced several LXR-responsive genes in wild-type mice, an impaired response was seen in the triple knockout mice ( 15 ) . Recently, it was found that 25-hydroxycholesterol binds to the Niemann-Pick, Type C1 protein, a protein involved in cholesterol transport from lysosomes to the endoplasmic reticulum ( 16 ) . Altogether, these studies suggest an important role for 25-hydroxycholesterol in the regulation of lipid metabolism.
Lipopolysaccharide (LPS; endotoxin) is an integral component of the cell wall of Gram-negative bacteria, such as Escherichia coli . LPS interaction with the Toll-like receptor 4 (TLR4), MD-2, and CD14 receptor complex induces a host response to invading pathogens. There are two main signaling pathways activated by TLR4, depending on the recruitment of separate sets of adaptor proteins: the Myeloid differentiation protein 88 (MyD88)-dependent pathway, involving Mal/TIRAP and MyD88, and the MyD88independent pathway, involving the TRIF and TRAM adaptors ( 17 ) . The MyD88-dependent pathway leads to activation of the transcription factor NF-B, whereas TRIF activates the transcription factor IRF3. Together, these pathways result in the induction of pro-infl ammatory genes with Bbinding motifs or the interferon-sensitive response element in their promoter regions.
During screening of genes upregulated by LPS treatment of bone marrow-derived mouse macrophages, it was unexpectedly found that cholesterol 25-hydroxylase was strongly upregulated. In this investigation, we have studied the LPS regulation of cholesterol 25-hydroxylase in mouse macrophages. We have also observed increased levels of plasma 25-hydroxycholesterol in healthy human volunteers exposed to endotoxin challenge.
EXPERIMENTAL PROCEDURES

Cell culture
The local Animal Care and Use Committee approved the experimental protocol used in the study, and all mice were bred in-house. Mice were anesthetized with isofl urane and euthanized by cervical dislocation. Bone marrow was isolated from 6 to 8 week old C57BL/6 and MyD88-defi cient mice. Macrophages were derived from these marrows by culture in DMEM media supplemented with 10% FBS and 10 ng/ml recombinant granulocytemacrophage colony-stimulating factor (GM-CSF) for 6 days. Bone marrow-derived macrophages were treated with either E. coli 0111 LPS (Sigma-Aldrich), 25-hydroxylcholesterol (Sigma-Aldrich), or control medium at the concentrations and times specifi ed below. The mouse macrophage-like cell line RAW264.7 was cultured in DMEM media supplemented with 10% FBS.
Microarray expression analysis
For microarray analysis of the mRNA expression profi le in bone marrow-derived macrophages, cells were treated at day 8 ex vivo for 2 h with 10 ng/ml E. coli 0111 LPS, and their gene expres-at Univ of Massachusetts Medical School Library, on March 6, 2020 www.jlr.org Downloaded from ( Fig. 1B ). Furthermore, the increased Ch25h expression was found to be independent of MyD88 signaling but dependent on TLR4 signaling, as the LPS-induced Ch25h expression was not impaired in mice with a targeted disruption of the MyD88 gene but severely impaired in TLR4-defi cient mice ( Fig. 1C ) . These data imply that LPSinduced Ch25h expression is controlled by the MyD88independent TLR4/TRIF dependent pathway.
To confi rm that the mRNA expression measured using microarrays was correct, we treated mouse bone 50 ng/ml 25-hydroxycholesterol for 18 h. Cells were also treated with 25 or 50 ng/ml 25-hydroxycholesterol 30 min prior to stimulation with LPS for 18 h. Culture media were collected and stored at Ϫ 80°C for cytokine analysis. The amount of released Chemokine (C-C motif) ligand 5 (CCL5; RANTES) was determined by ELISA according to the manufacturer's instructions (RnD Systems).
LPS injection in healthy subjects: study protocol
Healthy male volunteers (n = 8), age 26 ± 3 years, weight 74 ± 9 kg, length 182 ± 5 cm, and body mass index 22 ± 2 kg/m 2 (mean ± SD) participated in the study ( 20) . All subjects were metabolically and otherwise healthy, as determined by medical history, physical examination, analyses of cell blood count, and biochemical profi le. The study started in the morning at 8 AM after an overnight fast, and lasted for 8 h. At 4 h, all subjects received an intravenous injection of US Standard Reference E. coli endotoxin at 4 ng/kg (Lot EC-6; US Pharmacopeia). Venous blood samples were collected in evacuated tubes containing EDTA, before and 2 and 4 h after endotoxin administration. Informed consent was obtained from all subjects to participate in this study, which was approved by the local ethics committee of Karolinska Institutet at Huddinge University Hospital, Huddinge, Sweden.
The endotoxin model
Healthy volunteers were exposed to an endotoxin challenge. In small doses (4 ng/kg of body weight), endotoxin can safely be given to healthy individuals. It has been extensively used as a standardized human model for the early phase of sepsis ( 21, 22 ) . Endotoxin initiates the immune response. This response is clinically manifested as the systemic infl ammatory response syndrome of septic shock caused by Gram-negative bacteria. It should be recognized that administration of small doses of endotoxin is not a model of septic shock. Yet, endotoxin challenge elicits typical responses seen in sepsis, such as in hemodynamics, pulmonary function, metabolism, as well as in the coagulation/fi brinolytic function and in effects upon infl ammatory cells, although not as pronounced. The cytokine response shows a typical pattern with an early rise of the pro-infl ammatory mediators tumor necrosis factor-␣ , followed by interleukin-1 (IL-1), IL-6, and IL-8 similar to what is seen in sepsis ( 21, 22 ) . From a metabolical point of view, endotoxin challenge elicits pronounced changes in amino acid metabolism after 3 h with decreases of both plasma glutamate and glutamine by 25% ( 23 ) .
RESULTS
Expression of cholesterol 25-hydroxylase mRNA is increased by LPS treatment
While studying the expression profi le induced by LPS and live E. coli in mouse bone marrow-derived macrophages ( 18 ) , we noted that the expression of several genes involved in cholesterol and oxysterol metabolism were not changed considerably by LPS treatment with the exception of the cholesterol 25-hydroxlyase gene Ch25h ( Fig.  1A ). Ch25h mRNA expression was increased 35-fold ( P = ‫ف‬ 0.002) in macrophages treated with 10 ng/ml repurifi ed LPS for 2 h compared with medium-treated controls. The increased Ch25h mRNA expression was found to be transient with maximum expression reached at about 4 h after addition of LPS, and at 12 h, the expression had returned to a similar level of expression as before the LPS treatment Bone marrow-derived macrophages were differentiated in vitro with GM-CSF for 8 d and then treated with 10 ng/ml repurifi ed E.coli LPS or media only for 2 h (A). Total RNA was harvested, purifi ed, and labeled, and gene expression analyzed by microarrays (Operon) with oligonucleotide reporters representing approximately 13,000 genes. Cells from four individual mice were used and analyzed in duplicate (n = 8 microarrays total). In B, macrophages were treated with repurifi ed E. coli LPS, live E. coli (one bacterium per macrophage), or media only for 0, 0.5, 1, 2, 4, 6, 12, and 24 h as indicated. Each line represents macrophages taken from one individual mouse. In C, macrophages were derived from Tlr4 infl ammation. In Fig. 4B , pretreatment of RAW264.7 macrophages with 25 or 50 ng/ml 25-hydroxycholesterol for 30 min, prior to LPS treatment for 18 h, did not alter the amount of CCL5 released into the medium. RAW264.7 macrophages treated with increasing concentrations of 25hydroxycholesterol responded by producing CCL5 in a dose-dependent manner, confi rming that the small but signifi cant induction of CCL5 release was dependent on 25-hydroxycholesterol.
25-hydroxycholesterol increases in the plasma of healthy volunteers after LPS challenge
To test if 25-hydroxycholesterol levels are increased during human endotoxaemia and sepsis, we administered 4 ng/kg of US Standard Reference E. coli LPS by intravenous injection to eight healthy volunteers and measured plasma oxysterols in sampled blood over time. Blood plasma levels of 25-hydroxycholesterol were signifi cantly increased over baseline levels 4 h after endotoxin challenge ( Fig. 5 ). These results indicate that 25-hydroxycholesterol may play a role in human endotoxaemia and sepsis.
DISCUSSION
Very little is known about the regulation of cholesterol 25-hydroxylase. In an animal model where the gene responsible for the metabolism of 25-hydroxycholesterol, Cyp7b1, was disrupted, high circulatory levels of 25hydroxycholesterol and 27-hydroxycholesterol were observed ( 25 ) . These animals, lacking oxysterol 7 ␣ -hydroxylase, appeared to have a normal overall cholesterol metabolism, and no alterations in infl ammatory parameters were reported. Triple knockout mice defi cient in cholesterol 24-hydroxylase, cholesterol 25-hydroxylase, and sterol 27-hydroxylase have been generated and used in studies on LXR signaling. The gene disruptions resulted in reduced endogenous levels of 24-, 25-, and 27-hydroxycholesterol to below levels of detection. However, phenotypic data on these mice were not reported (1 5 ) . It has been reported previously that 25-hydroxy vitamin D 3 and 1,25dihydroxy vitamin D 3 can upregulate cholesterol 25hydroxylase in human primary prostate stromal cells ( 26 ) . In this work, we show that LPS induces cholesterol 25-hydroxylase mRNA expression, which is accompanied by increased 25-hydroxycholesterol release from mouse macrophages.
marrow-derived macrophages with either PBS or 10 ng/ ml repurifi ed E. coli LPS for 2 h and analyzed the mRNA expression by quantitative real-time PCR. Ch25h mRNA was found to be increased in LPS-treated macrophages by 51-fold over PBS-treated control macrophages, whereas Cyp27a1 and Cyp7b1 mRNA was not changed compared with control macrophages ( Fig. 2 A-C ) . The LPS-induced upregulation of Ch25h mRNA expression presented a possibility that 25-hydroxycholesterol may have a function in infl ammation separate from other oxysterols.
25-hydroxycholesterol production and release from mouse macrophages is increased upon LPS treatment
To study if LPS treatment of macrophages also induces the production and release of 25-hydroxycholesterol, we treated mouse bone marrow-derived macrophages with 10 ng/ml LPS for 6 or 24 h. The medium from untreated and LPS-treated cells was saved, and the adherent macrophages were thoroughly washed with PBS before they were scraped. Cellular oxysterols and oxysterols released into culture medium were extracted and analyzed by GC-MS and normalized to total cellular protein. LPS treatment increased macrophage 25-hydroycholesterol by 6-to 7-fold compared with untreated cells ( Fig. 3B ) and increased 25hydroxycholesterol released into the culture medium by 1.5-fold at 6 h and by 2.2-fold at 24 h.
25-hydroxycholesterol induces release of pro-infl ammatory CCL5 cytokine but does not inhibit LPS-induced CCL5 release
To investigate if 25-hydroxycholesterol may have a function in promoting infl ammation, we treated RAW264.7 mouse macrophages with 25 or 50 ng/ml 25-hydroxycholesterol for 18 h and then measured CCL5 released into the medium normalized to total cellular protein. This is the same oxysterol concentrations found to be released from macrophages upon LPS treatment ( Fig. 3A ) . Administration of CCL5 has previously been shown to increase sepsis-induced lethality in a cecal ligation and puncture model of septic peritonitis in mice, whereas CCL5 neutralization improved survival ( 24 ) . The 25-hydroxycholesterol treatment induced a small but signifi cant increase in CCL5 released into the medium compared with control macrophages. Next, to study if 25-hydroxycholesterol might have a role in limiting infl ammation, we reasoned that pretreatment of macrophages with 25-hydroxycholesterol might impair LPS-induced release of CCL5, thus limiting at Univ of Massachusetts Medical School Library, on March 6, 2020 www.jlr.org
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It has been reported previously that LPS treatment markedly decreased the activity and mRNA levels of CYP27 in livers from Syrian hamsters and mice ( 34 ) . In this study, no such decrease was observed in the mouse macrophages after 2 h ( Fig. 2 ) . Furthermore, LPS treatment of healthy volunteers did not alter plasma levels of 27-hydroxycholesterol during the time window studied (data not shown).
It has been shown previously that 25-hydroxycholesterol stimulates the release of pro-infl ammatory cytokines in several cellular systems. Treatment of human monocytes or THP-1 cells with 25-hydroxycholesterol stimulated the release of IL-8 ( 27, 28 ) . Enhanced pro-infl ammatory cytokine secretion was also observed in U937 cells after 25-hydroxycholesterol challenge ( 29, 30 ) . This oxysterol also caused a dose-dependent increase in IL-1 ␤ secretion from human monocyte-derived macrophages and in addition stimulated IL-1 ␤ secretion induced by LPS ( 28 ) . 25-Hydroxycholesterol treatment resulted in an enhanced production of both IL-1 ␤ and IL-8 in Caco-2 cells ( 31 ) and was also shown to be a potent inducer of infl ammation in retinal pigment epithelial cells ( 32 ) . In macrophages, the pro-infl ammatory cytokine CCL5 has been shown to have a critical role for cell survival ( 33 ) ; consequently, we studied the effect of 25-hydroxycholesterol on the release of CCL5 from mouse macrophages. Although a dose-dependent release of CCL5 was observed, the amount released was so low compared with LPS-induced CCL5 release that it can be questioned if it has any biological meaning. On the other hand, it may be that tissue macrophages have a higher production of cytokines compared with isolated cells. Liu, Hulten, and Wiklund ( 27 ) showed that tissue macrophages produced 7 times more IL-8 than monocytes and 100 times more than monocyte-derived macrophages. 
